# EFX — Equifax Inc. · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** EFX  
**Sources:** 23  
**Published:** 2026-10-25  
**Canonical:** https://app.k3vl4r.com/research/deep-research-efx-equifax-inc-catalysts-narrative-risks-9124

---

## Equifax Inc. (NYSE: EFX) — Research Snapshot as of 2026-10-25

**Price context:** EFX closed at $182.36 on October 23, 2026, with a market capitalization of roughly $21.4 billion [[18]](https://stockanalysis.com/stocks/efx/forecast/), [[22]](https://public.com/stocks/efx/forecast-price-target), [[23]](https://clearank.com/stock/efx-stock-analysis/). The stock remains well below its peak — down about 21% year-over-year and with a wide 52-week range of roughly $137 to $234–239, depending on the source's reference date [[17]](https://tickernerd.com/stock/efx-forecast/), [[18]](https://stockanalysis.com/stocks/efx/forecast/), [[23]](https://clearank.com/stock/efx-stock-analysis/). (Note: some earlier snapshots show a 52-week high near $262 and a lower market cap of ~$18.7 billion, reflecting older data as of mid-September 2026 [[11]](https://www.ad-hoc-news.de/boerse/news/corporate-news/equifax-stock-slips-as-analysts-lift-target-to-235/70136485), so figures should be read as point-in-time.)

## Key Recent Catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-efx-equifax-inc-catalysts-narrative-risks-9124 (free to sign up)._
